Pharmaceuticals, Biotechnology and Life Sciences
Teva recalls 35 lots of bulk LosartanPotassium USP Tablets.
DUBLIN–(BUSINESS WIRE)–The “Drug Addiction – Pipeline Review, H1 2019” report has been added to ResearchAndMarkets.com’s offering. Drug Addiction – Pipeline…
DUBLIN–(BUSINESS WIRE)–The “Multiple Myeloma: Epidemiology Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. In 2017, the 8MM had…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026” report has been added to ResearchAndMarkets.com’s offering. “Idiopathic Pulmonary Fibrosis: Competitive…
Teva is discontinuing the clinical developmentprogram for use of fremanezumab in cluster headaches.
Teva has launched generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S.
The global anticoagulants reversal drugs market expected to expand at aCAGR of 15.3% from 2018 to 2026, owing to the approval of blockbusterdrugs in recent years and strong pipeline driving the market.
DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DUBLIN–(BUSINESS WIRE)–The “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that it has expanded its existing…